keyword
https://read.qxmd.com/read/38524223/clinical-and-epidemiological-characteristics-of-the-2022-mpox-outbreak-in-spain-ceme-22-study
#21
JOURNAL ARTICLE
G Ramírez-Olivencia, M Velasco Arribas, M M Vera García, J Casabona, M J Martínez, F J Membrillo De Novales
BACKGROUND: We conducted a multicentric national study (SEIMC-CEME-22), to describe the clinical and epidemiological profile of the mpox outbreak in Spain, including the management of the disease. METHODS: This was a retrospective national observational study conducted by Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) and Foundation SEIMC-GESIDA. We included patients with a confirmed mpox diagnosis before 13 July 2022, and attended at the Spanish health network (the early phase of the outbreak)...
March 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38523492/effect-of-hepatic-impairment-on-the-pharmacokinetics-of-fenfluramine-and-norfenfluramine
#22
JOURNAL ARTICLE
Aravind Mittur, Ryan Madanick, Melanie Langlois, Brooks Boyd
Fenfluramine (Fintepla® ) is approved for the treatment of seizures associated with the rare epileptic encephalopathies Dravet syndrome and Lennox-Gastaut syndrome. Fenfluramine is extensively metabolized; thus, patients with hepatic impairment (HI) might experience changes in exposure to fenfluramine or its metabolites. In this phase 1 study, we investigated the pharmacokinetics (PK) and safety of a single oral dose of 0.35 mg/kg fenfluramine in subjects with mild (n = 8), moderate (n = 8), or severe (n = 7) HI (Child-Pugh A/B/C, respectively) and healthy control subjects (n = 22) matched for sex, age, and BMI...
March 25, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38520128/pharmacokinetics-and-safety-of-firsocostat-an-acetyl-coenzyme-a-carboxylase-inhibitor-in-participants-with-mild-moderate-and-severe-hepatic-impairment
#23
JOURNAL ARTICLE
Islam R Younis, Cara Nelson, Elijah J Weber, Ann R Qin, Timothy R Watkins, Ahmed A Othman
Firsocostat is an oral, liver-targeted inhibitor of acetyl-coenzyme A carboxylase in development for the treatment of metabolic dysfunction-associated steatohepatitis. Hepatic organic anion transporting polypeptides play a significant role in the disposition of firsocostat with minimal contributions from uridine diphospho-glucuronosyltransferase and cytochrome P450 3A enzymes. This phase 1 study evaluated the pharmacokinetics and safety of firsocostat in participants with mild, moderate, or severe hepatic impairment...
March 22, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38515187/hypermethylation-of-the-glutathione-peroxidase-4-gene-promoter-is-associated-with-the-occurrence-of-immune-tolerance-phase-in-chronic-hepatitis-b
#24
JOURNAL ARTICLE
Xing Su, Zhaohui Wang, Jihui Li, Shuai Gao, Yuchen Fan, Kai Wang
BACKGROUND: Hepatitis B virus (HBV) infection is a public health problem that seriously threatens human health. This study aimed to investigate the clinical significance of glutathione peroxidase 4(GPX4) in the occurrence and development of chronic hepatitis B (CHB). METHODS: A total of 169 participants including 137 patients with CHB and 32 healthy controls (HCs) were recruited. We detected the expression of GPX4 and stimulator of interferon genes (STING) in peripheral blood mononuclear cells (PBMCs) by real-time quantitative polymerase chain reaction (RT-qPCR)...
March 21, 2024: Virology Journal
https://read.qxmd.com/read/38513684/safety-and-immunogenicity-of-the-co-administered-na-apr-1-and-na-gst-1-hookworm-vaccines-in-school-aged-children-in-gabon-a-randomised-controlled-observer-blind-phase-1-dose-escalation-trial
#25
JOURNAL ARTICLE
Jeannot F Zinsou, David J Diemert, Jean Claude Dejon-Agobé, Bayodé R Adégbité, Yabo Josiane Honkpehedji, Kafui G Vodonou, Rodrigue Bikangui, Jean Ronald Edoa, Marguerite Massinga Loembe, Guangzhao Li, Maria Yazdanbakhsh, Maria Elena Bottazzi, Remko van Leeuwen, Peter G Kremsner, Peter J Hotez, Jeffrey M Bethony, Martin P Grobusch, Ayola A Adegnika
BACKGROUND: A human hookworm vaccine is being developed to protect children against iron deficiency and anaemia associated with chronic infection with hookworms. Necator americanus aspartic protease-1 (Na-APR-1) and N americanus glutathione S-transferase-1 (Na-GST-1) are components of the blood digestion pathway critical to hookworm survival in the host. Recombinant Na-GST-1 and catalytically inactive Na-APR-1 (Na-APR-1[M74]) adsorbed to Alhydrogel were safe and immunogenic when delivered separately or co-administered to adults in phase 1 trials in non-endemic and endemic areas...
March 18, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38510983/long-term-open-label-vebicorvir-for-chronic-hbv-infection-safety-and-off-treatment-responses
#26
JOURNAL ARTICLE
Man-Fung Yuen, Scott Fung, Xiaoli Ma, Tuan T Nguyen, Tarek Hassanein, Hie-Won Hann, Magdy Elkhashab, Ronald G Nahass, James S Park, Ira M Jacobson, Walid S Ayoub, Steven-Huy Han, Edward J Gane, Katie Zomorodi, Ran Yan, Julie Ma, Steven J Knox, Luisa M Stamm, Maurizio Bonacini, Frank Weilert, Alnoor Ramji, Michael Bennett, Natarajan Ravendhran, Sing Chan, Douglas T Dieterich, Paul Yien Kwo, Eugene R Schiff, Ho S Bae, Jacob Lalezari, Kosh Agarwal, Mark S Sulkowski
BACKGROUND & AIMS: The investigational first-generation core inhibitor vebicorvir (VBR) demonstrated safety and antiviral activity over 24 weeks in two phase IIa studies in patients with chronic HBV infection. In this long-term extension study, patients received open-label VBR with nucleos(t)ide reverse transcriptase inhibitors (NrtIs). METHODS: Patients in this study (NCT03780543) previously received VBR + NrtI or placebo + NrtI in parent studies 201 (NCT03576066) or 202 (NCT03577171)...
April 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38499260/chishao-fuzi-herbal-pair-restore-the-macrophage-m1-m2-balance-in-acute-on-chronic-liver-failure
#27
JOURNAL ARTICLE
Nianhua Tan, Gonghui Jian, Jie Peng, Xuefei Tian, Bin Chen
ETHNOPHARMACOLOGICAL RELEVANCE: Traditional herbal pair Paeoniae Radix Rubra (roots of Paeonia lactiflora Pall., Chishao in Chinese) and Aconiti Lateralis Radix Praeparata (lateral roots of Aconitum carmichaelii Debeaux, Fuzi in Chinese) are widely used for the treatment of liver diseases, demonstrating clinical efficacy against acute-on-chronic liver failure (ACLF). As the core drug pair representing the "clearing method" and "warming method" in traditional Chinese medicine (TCM), they align with the TCM syndromic characteristics of ACLF, characterized by a mixture of deficiencies and realities...
June 28, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38497865/therapeutic-potential-of-ramipril-losartan-and-spironolactone-against-sepsis-associated-liver-tissue-injury-induced-by-cecal-ligation-and-puncture-in-rats
#28
JOURNAL ARTICLE
A Al-Kadi, M El-Daly, N F G El-Tahawy, O Fahmi, A B Abdel-Naim, M M A Khalifa, A F Ahmed
OBJECTIVE: Sepsis-associated liver injury is responsible for the high morbidity and mortality rates seen with septic shock. Activation of the renin-angiotensin-aldosterone system (RAAS) is an essential counteractive mechanism during the hypotensive phase of sepsis; however, excessive activation is associated with exaggerated pro-oxidant and inflammatory response, which aggravates organ damage. This study aimed to evaluate the effect of RAAS inhibition on sepsis-induced liver damage. MATERIALS AND METHODS: The cecal ligation and puncture (CLP) model was employed as a model of sepsis...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38489403/combination-of-an-autoantibody-panel-and-alpha-fetoprotein-for-early-detection-of-hepatitis-b-virus-associated-hepatocellular-carcinoma
#29
JOURNAL ARTICLE
Yajing Shen, Jiajun Chen, Jinyu Wu, Tiandong Li, Chuncheng Yi, Keyan Wang, Peng Wang, Changqing Sun, Hua Ye
The purpose of this study was to identify biomarkers associated with hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) and to develop a new combination with good diagnostic performance. This study was divided into four phases: discovery, verification, validation and modeling. A total of four candidate tumor-associated autoantibodies (TAAbs) (anti-ZIC2, anti-PCNA, anti-CDC37L1, and anti-DUSP6) were identified by human proteome microarray (52 samples) and bioinformatics analysis. Subsequently, these candidate TAAbs were further confirmed by indirect enzyme-linked immunosorbent assay (ELISA) with two testing cohorts (120 samples for verification and 663 samples for validation)...
March 15, 2024: Cancer Prevention Research
https://read.qxmd.com/read/38481490/providing-hemodialysis-in-unstable-areas-an-assessment-and-framework-for-effective-care
#30
JOURNAL ARTICLE
Sami Alasfar, Hani Alashavi, Khaled Hajj Nasan, Abd Aljabbar Haj Mousa, Camila Polinori, Valerie Luyckx, Mohamed Sekkarie, Saleh Kaysi, Lina Murad, Gilbert M Burnham
INTRODUCTION: Providing hemodialysis to patients with kidney failure (KF) in conflict-affected areas poses a significant challenge. Achieving and sustaining reasonable quality hemodialysis operations in such regions necessitates a comprehensive approach. METHODS: In the conflict area of Northwest (NW) Syria, a 3-phase project was initiated to address the quality of hemodialysis operations. The assessment phase involved the examination of infection prevention and control (IPC) protocols, staff training, medical protocols, individualized hemodialysis prescriptions, and laboratory testing capabilities...
March 2024: KI Reports
https://read.qxmd.com/read/38473998/simultaneous-purification-of-human-interferon-alpha-2b-and-serum-albumin-using-bioprivileged-fluorinated-ionic-liquid-based-aqueous-biphasic-systems
#31
JOURNAL ARTICLE
Sara F Carvalho, Ana B Pereiro, João M M Araújo
Interferon alpha-2b (IFN-α2b) is an essential cytokine widely used in the treatment of chronic hepatitis C and hairy cell leukemia, and serum albumin is the most abundant plasma protein with numerous physiological functions. Effective single-step aqueous biphasic system (ABS) extraction for the simultaneous purification of IFN-α2b and BSA (serum albumin protein) was developed in this work. Effects of the ionic liquid (IL)-based ABS functionalization, fluorinated ILs (FILs; [C​2C​1Im][C​4F​9SO​3] and [N​1112(OH)][C​4F​9SO​3]) vs...
February 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38471254/impurity-assessment-development-and-validation-of-an-rp-hplc-method-for-the-determination-of-eleven-potential-impurities-of-eltrombopag-precursor
#32
REVIEW
Timur Demirhan, Elif Guksu, Yücel Yazar, Elif Keskin, Esen Bellur Atici, Sibel A Özkan
Eltrombopag is an oral non-peptide thrombopoietin receptor (TPO-R) agonist indicated for the treatment of thrombocytopenia in patients with persistent or chronic immune thrombocytopenia (idiopathic thrombocytopenic purpura, ITP) or chronic hepatitis C infection and the treatment of severe aplastic anemia. The purpose of this research was to assess the possible impurities that may carry over to eltrombopag from its precursor Eltro-1 (3'-amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid) and to develop a specific analytical method for the determination of these impurities...
March 6, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38464387/the-oncogenic-role-of-hepatitis-b-virus-x-gene-in-hepatocarcinogenesis-recent-updates
#33
REVIEW
Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi, Sri Jayanti, Caecilia Sukowati
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers with high mortality rate. Among its various etiological factors, one of the major risk factors for HCC is a chronic infection of hepatitis B virus (HBV). HBV X protein (HBx) has been identified to play an important role in the HBV-induced HCC pathogenesis since it may interfere with several key regulators of many cellular processes. HBx localization within the cells may be beneficial to HBx multiple functions at different phases of HBV infection and associated hepatocarcinogenesis...
2024: Exploration of targeted anti-tumor therapy
https://read.qxmd.com/read/38456992/mining-phase-separation-related-diagnostic-biomarkers-for-endometriosis-through-wgcna-and-multiple-machine-learning-techniques-a-retrospective-and-nomogram-study
#34
JOURNAL ARTICLE
Qiuyi Liang, Shengmei Yang, Meiyi Mai, Xiurong Chen, Xiao Zhu
OBJECTIVE: The objective of this study was to investigate the role of phase separation-related genes in the development of endometriosis (EMs) and to identify potential characteristic genes associated with the condition. METHODS: We used GEO database data, including 74 non-endometriosis and 74 varying-degree EMs patients. Our approach involved identifying significant gene modules, exploring gene intersections, identifying core genes, and screening for potential EMs biomarkers using weighted gene co-expression network analysis (WGCNA) and various machine learning approaches...
March 8, 2024: Journal of Assisted Reproduction and Genetics
https://read.qxmd.com/read/38456707/pharmacokinetics-of-long-acting-lenacapavir-in-participants-with-hepatic-or-renal-impairment
#35
JOURNAL ARTICLE
Vamshi Jogiraju, Elijah Weber, Jason Hindman, Steve West, John Ling, Martin Rhee, Sandhya Girish, Ramesh Palaparthy, Renu Singh
Lenacapavir is a novel, first-in-class, multistage inhibitor of HIV-1 capsid function approved for the treatment of multidrug-resistant HIV-1 infection in combination with other antiretrovirals for heavily treatment-experienced people with HIV. Two Phase 1, open-label, parallel-group, single-dose studies assessed the pharmacokinetics (PK) of lenacapavir in participants with moderate hepatic impairment [Child-Pugh-Turcotte (CPT) Class B: score 7-9] or severe renal impairment [15 ≤ creatinine clearance (CLcr) ≤29 mL/min] to inform lenacapavir dosing in HIV-1-infected individuals with organ impairment...
March 8, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38440978/stat3-activation-triggered-transcriptional-networks-govern-the-early-stage-of-hbv-induced-hepatic-inflammation
#36
JOURNAL ARTICLE
Jinglin Tang, Jiaxuan Zhang, Gaoli Zhang, Wenhui Peng, Ning Ling, Yingzhi Zhou, Hongmei Xu, Hong Ren, Min Chen
UNLABELLED: The chronic carrier state of the hepatitis B virus (HBV) often leads to the development of liver inflammation as carriers age. However, the exact mechanisms that trigger this hepatic inflammation remain poorly defined. We analyzed the sequential processes during the onset of liver inflammation based on time-course transcriptome and transcriptional regulatory networks in an HBV transgenic (HBV-Tg) mice model and chronic HBV-infected (CHB) patients (data from GSE83148). The key transcriptional factor (TF) responsible for hepatic inflammation occurrence was identified and then validated both in HBV-Tg mice and liver specimens from young CHB patients...
March 5, 2024: MBio
https://read.qxmd.com/read/38434681/comparative-efficacy-and-safety-of-multimodality-treatment-for-advanced-hepatocellular-carcinoma-with-portal-vein-tumor-thrombus-patient-level-network-meta-analysis
#37
John Hang Leung, Shyh-Yau Wang, Henry W C Leung, Agnes L F Chan
BACKGROUND: Portal vein tumor thrombus (PVTT) is a common complication and an obstacle to treatment, with a high recurrence rate and poor prognosis. There is still no global consensus or standard guidelines on the management of hepatocellular carcinoma (HCC) with PVTT. Increasing evidence suggests that more aggressive treatment modalities, including transarterial chemoembolization, radiotherapy, targeted therapy, and various combination therapies, may improve the prognosis and prolong the survival of advanced hepatocellular carcinoma (aHCC) patients with PVTT...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38425451/hepatitis-b-surface-antigen-expression-impairs-endoplasmic-reticulum-stress-related-autophagic-flux-by-decreasing-lamp2
#38
JOURNAL ARTICLE
Yaojie Liang, Xufeng Luo, Stefan Schefczyk, Lorraine T Muungani, Hui Deng, Baoju Wang, Hideo A Baba, Mengji Lu, Heiner Wedemeyer, Hartmut H Schmidt, Ruth Broering
BACKGROUND & AIMS: Hepatitis B surface antigen (HBsAg) drives hepatocarcinogenesis. Factors and mechanisms involved in this progression remain poorly defined, hindering the development of effective therapeutic strategies. Therefore, the mechanisms involved in the HBsAg-induced transformation of normal liver into hepatocellular carcinoma (HCC) were investigated. METHODS: Hemizygous Tg(Alb1HBV)44Bri/J mice were examined for HBsAg-induced carcinogenic events. Gene set-enrichment analysis identified significant signatures in HBsAg-transgenic mice that correlated with endoplasmic reticulum (ER) stress, unfolded protein response, autophagy and proliferation...
April 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38415116/a-convenient-and-reproducible-protocol-for-acquisition-of-the-hepatocyte-phase-for-liver-function-impaired-patients-in-gadoxetic-acid-disodium-enhanced-magnetic-resonance-imaging
#39
JOURNAL ARTICLE
Chao Wang, Wei-Rong Sun, Ning Wu, Zhuang Zhang, Lai-Xing Zhang, Wan-Qing Yi, Xiao-Dong Yuan
BACKGROUND: The hepatocyte phase (HCP) in gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) plays an important role in the detection and characterization of liver lesions, treatment planning, and liver function evaluation. However, the imaging protocol is complicated and time-consuming. This cross-sectional study aimed to develop a convenient and reproducible protocol for the HCP acquisition in Gd-EOB-DTPA-enhanced MRI. METHODS: A total of 107 patients were prospectively included and assigned to three groups based on Child-Pugh (CP) classification, with 37, 40, and 30 in the non-cirrhosis, CP A, and CP B groups, respectively...
February 1, 2024: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/38407853/can-quantitative-surface-antigen-levels-and-systemic-immune-inflammation-index-be-predictive-as-a-new-indicator-for-the-initiation-of-treatment-in-chronic-hepatitis-b
#40
JOURNAL ARTICLE
Mehmet Koroglu, Muhammed Ali Ayvaz, Suat Baran Bakan, Abdullatif Sirin, Umit Akyuz
OBJECTIVES: The natural history of chronic HBV infection (CHB) is generally divided into four phases: HBeAg-positive chronic HBV infection (EPCI) and -hepatitis (EPCH), HBeAg-negative chronic HBV infection (ENCI) and -hepatitis (ENCH). This study aimed to investigate changes in serum quantitative surface antigen (qHBsAg), systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) in a large number of CHB patients. METHOD: Three hundred seventy-two CHB patients who underwent liver biopsy between January 2015 and February 2020 were evaluated...
February 21, 2024: European Journal of Gastroenterology & Hepatology
keyword
keyword
71570
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.